These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4392861)

  • 1. [Propericiazine and behavior disorders in neurological diseases in childhood and adolescence].
    Giménez Roldán S; Campos Castelló J
    Arch Neurobiol (Madr); 1969; 32(3):331-46. PubMed ID: 4392861
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of propericiazine on behavior disorders of children and adolescents].
    Duche DJ
    Laval Med; 1970 Jun; 41(6):784-8. PubMed ID: 4396436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the study of the effect of propericiazine on character and behavior disorders observed in children and adolescents].
    Duché DJ; Bourcier G
    Rev Neuropsychiatr Infant; 1969 Mar; 17(3):165-71. PubMed ID: 4389568
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of oligophrenic children and adolescents with propericiazine].
    Dostál T
    Act Nerv Super (Praha); 1968 Oct; 10(3):319. PubMed ID: 4387432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results of the use of 8909--Neuleptil--in child psychiatry].
    Penna JM; Baptistette E; de Souza EA; dos Santos CC; Fonesca CA
    Hospital (Rio J); 1966 Oct; 70(4):973-9. PubMed ID: 4385327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with propericiazine in the treatment of functional psychomotor disorders and states of restlessness in childhood].
    Seebandt G
    Arzneimittelforschung; 1970 Jul; 20(7):937-9. PubMed ID: 4394249
    [No Abstract]   [Full Text] [Related]  

  • 7. Propericiazin, diazepam, chlorpromazine and placebo in a doubleblind trial in pedopsychiatric therapy.
    Bartůnková Z; Cerný L; Drtilová J; Sturma J
    Act Nerv Super (Praha); 1972; 14(2):83-4. PubMed ID: 4402693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Utilization of propericiazine in treatment of character disorders in mentally retarded children and adolescents].
    Vaneck L
    Rev Neuropsychiatr Infant; 1969 Aug; 17(8):557-61. PubMed ID: 4391428
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attempts at treatment of children at a special institution with propericiazine].
    Wiecek Z
    Psychiatr Pol; 1971; 5(1):61-3. PubMed ID: 4396404
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the treatment of character and behavior disorders by propericiazine as compared with earlier treatments].
    Filipe-Lourenço A; Lécuyer R; Koupernik C
    Rev Neuropsychiatr Infant; 1966; 14(7):617-24. PubMed ID: 4382962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical considerations concerning the evaluation of the clinical effects of a so-called "socializing" drug (propericiazine)].
    Del Pistoia L; De Risio C; Ridolo P
    Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1365+. PubMed ID: 4387970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bad character and Neuleptil. Apropos of a Belgian and Luxembourgian clinical experiment (1963-1964)].
    Bobon J; Gernay JM; Collard J; Goffioul F; Breulet M
    Acta Neurol Psychiatr Belg; 1968 Feb; 68(2):154-62. PubMed ID: 4387055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical remarks on the therapeutic activity of propericiazine].
    Nava V
    G Psichiatr Neuropatol; 1967; 95(1):127-51. PubMed ID: 4386098
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of propericiazine in the treatment of certain primary pruritus of psychogenic origin].
    Bolgert M; Piret JM
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):490-3. PubMed ID: 4384749
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical study with propericiazine in chronic psychotic patients.
    Deutsch M; Ananth JV; Ban TA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with propericiazine or an adjuvant in the therapy of epileptic syndromes].
    Proto A; Gentilucci C
    G Psichiatr Neuropatol; 1968; 96(4):819-33. PubMed ID: 4391103
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correction of stable mental changes in children with epilepsy].
    Kaubish VK; Saldina LP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1563-6. PubMed ID: 4400383
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-neuroleptic studies of the neuroleptic agent Propericiazine with special consideration of the neuroleptic threshold].
    Haase HJ; Deinzer C; Rhinow E
    Med Welt; 1968 Jul; 27():1580-4. PubMed ID: 4388432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of propericiazine (Neuleptil) on the Rorschach psychodiagnostic test in children during differential treatment].
    Ronco P; Mezzena G; Priora PM
    Minerva Med; 1968 Jul; 59(53):3003-7. PubMed ID: 4386141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychological changes during propericiazine (Neuleptil) treatment of adolescents with scholastic adaptation difficulties].
    Ronco P; Davy M
    Minerva Med; 1968 May; 59(40):2357-64. PubMed ID: 5653334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.